TYPE 1 DIABETES MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

Global type 1 diabetes market faces several challenges. Due to the complex nature of the disease, developing innovative treatment options requires extensive research and clinical trials, resulting in high costs. The routes of insulin administration currently available pose pain and inconvenience challenges for patients. The involvement of multiple devices and manual oversight of insulin dosing regimens place a high treatment burden on patients. Maintaining strict glucose control also poses risks of hypoglycemia. As the underlying cause of type 1 diabetes is still unknown, a permanent cure remains elusive.

Market Opportunities: Developing technologically advanced insulin delivery systems

Newer insulin delivery technologies that are being researched aim to address some of the shortcomings of existing options and provide better management of the condition. For example, closed loop insulin delivery systems which are also called artificial pancreas systems automatically monitor blood glucose levels using a continuous monitor and calculate and deliver the required insulin dose via an infusion pump. This helps reduce the burden of numerous blood glucose checks and insulin administration decisions on patients.